Medpace
MEDP
693 hedge funds and large institutions have $13B invested in Medpace in 2026 Q2 according to their latest regulatory filings, with 72 funds opening new positions, 202 increasing their positions, 308 reducing their positions, and 101 closing their positions.
13% more capital invested
Capital invested by funds: $11.5B → $13B (+$1.5B)
1.34% more ownership
Funds ownership: 84.93% → 86.27% (+1.3%)
5% less funds holding
Funds holding: 732 → 693 (-39)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
29% less first-time investments, than exits
New positions opened: 72 | Existing positions closed: 101
34% less repeat investments, than reductions
Existing positions increased: 202 | Existing positions reduced: 308
77% less call options, than puts
Call options by funds: $22.5M | Put options by funds: $98M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$822M |
| 2 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$72.4M |
| 3 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$60.4M |
| 4 |
EIP
Epoch Investment Partners
New York
|
+$58M |
| 5 |
Goldman Sachs
New York
|
+$38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$91.4M |
| 2 |
Mawer Investment Management
Calgary,
Alberta, Canada
|
-$82.6M |
| 3 |
Two Sigma Investments
New York
|
-$77M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$63.4M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$49.1M |
MEDP Hedge Fund Activity: Q2 2026 in Review
693 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q2 2026, worth a combined $13B — up 13% from $11.5B a quarter earlier.
Sellers outnumbered buyers: 101 funds closed out of MEDP and 72 opened new positions — a net loss of 29 holders — while 308 trimmed existing stakes and 202 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $822M. The largest seller was D.E. Shaw & Co, cutting an estimated $91.4M.
- 693 institutional investors held Medpace (MEDP) as of Q2 2026, down from 732 in Q1 2026.
- Funds reported $13B of Medpace stock for Q2 2026, up 13% quarter-over-quarter.
- 72 funds opened new Medpace positions in Q2 2026 and 101 closed out, a net change of -29 holders.
- The largest Medpace buyer in Q2 2026 was T. Rowe Price Associates, an estimated $822M added.
- The largest Medpace seller in Q2 2026 was D.E. Shaw & Co, an estimated $91.4M sold.
Based on aggregated 13F filings for Q2 2026.